Topic: Biology
Scientists from Pusan National University developed nanoparticles that deliver antibiotics directly to H. pylori bacteria, which cause stomach ulcers and cancer. These nanoparticles successfully reached the infection site and reduced bacterial growth by 99.9%. This breakthrough could lead to more effective treatment of gastric ulcers.
Helicobacter pylori (H. pylori) bacteria infect around half of the global population and are a leading cause of stomach ulcers and cancer. Antibiotics are often used to treat H. pylori infections, but they can fail to reach the bacteria hidden beneath the stomach's protective mucus layer.
To address this challenge, researchers from Pusan National University developed polydopamine-functionalized, clarithromycin-loaded PLGA nanoparticles designed to deliver antibiotics directly to the infection site. These nanoparticles were fabricated using a nanoprecipitation method followed by a polydopamine surface coating. Their physicochemical properties were thoroughly characterized.
The platform was then evaluated through in vitro, ex vivo and in vivo studies that assessed mucus penetration, bacterial adhesion, gastric retention, tissue penetration, antibacterial activity and therapeutic efficacy in a mouse model of H. pylori-infected gastric ulcers. The engineered nanoparticles successfully completed each stage of the delivery cascade.
They remained stable under acidic gastric conditions, minimized premature clarithromycin release, penetrated the gastric mucus barrier, selectively accumulated at ulcer sites and reached approximately 400 μm into ulcer tissue, where deep-seated H. pylori reside. The polydopamine coating also enabled strong, ligand-independent bacterial adhesion, allowing localized antibiotic release directly at the infection site.
This precision targeting achieved approximately 99.9% bacterial reduction, accelerated ulcer healing, prolonged gastric retention and promoted tissue regeneration. Notably, these therapeutic benefits were achieved using a 10-fold lower dose of clarithromycin than conventional systemic therapy.
Why It Matters
This breakthrough could lead to more effective treatment of gastric ulcers, which are a major health concern in India. According to the World Health Organization (WHO), H. pylori infections cause over 3 million deaths worldwide each year.
Key Facts
- H. pylori bacteria infect around half of the global population and cause stomach ulcers and cancer.
- Scientists from Pusan National University developed nanoparticles that deliver antibiotics directly to H. pylori bacteria.
- These nanoparticles successfully reached the infection site and reduced bacterial growth by 99.9%.
- The breakthrough could lead to more effective treatment of gastric ulcers, reducing the risk of antibiotic resistance.
- The study was published in the Journal of Controlled Release on June 10, 2026.
Key Terms
- PLGA
- A type of biodegradable polymer used to create nanoparticles.
- Polydopamine
- A molecule that helps nanoparticles stick to bacteria and deliver antibiotics.
Implications
This breakthrough could lead to more effective treatment of gastric ulcers, which are a major health concern in India. According to the World Health Organization (WHO), H. pylori infections cause over 3 million deaths worldwide each year.
Leave a comment